210 related articles for article (PubMed ID: 27578920)
1. Gene Expression and Proteome Analysis as Sources of Biomarkers in Basal Cell Carcinoma.
Lupu M; Caruntu C; Ghita MA; Voiculescu V; Voiculescu S; Rosca AE; Caruntu A; Moraru L; Popa IM; Calenic B; Greabu M; Costea DE
Dis Markers; 2016; 2016():9831237. PubMed ID: 27578920
[TBL] [Abstract][Full Text] [Related]
2. p16 gene expression in basal cell carcinoma.
Eshkoor SA; Ismail P; Rahman SA; Oshkour SA
Arch Med Res; 2008 Oct; 39(7):668-73. PubMed ID: 18760195
[TBL] [Abstract][Full Text] [Related]
3. Microarray profiles of human basal cell carcinoma: insights into tumor growth and behavior.
Howell BG; Solish N; Lu C; Watanabe H; Mamelak AJ; Freed I; Wang B; Sauder DN
J Dermatol Sci; 2005 Jul; 39(1):39-51. PubMed ID: 15978418
[TBL] [Abstract][Full Text] [Related]
4. Nodular basal cell carcinoma is associated with increased hyaluronan homeostasis.
Tzellos TG; Kyrgidis A; Vahtsevanos K; Triaridis S; Printza A; Klagas I; Zvintzou E; Kritis A; Karakiulakis G; Papakonstantinou E
J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):679-87. PubMed ID: 20849445
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor in basal cell carcinomas.
Stoebner PE; Le Gallic L; Berthe ML; Boulle N; Lallemant B; Marque M; Gaspard C; Delfour C; Lavabre-Bertrand T; Martinez J; Meunier L
Exp Dermatol; 2008 Nov; 17(11):908-15. PubMed ID: 18341568
[TBL] [Abstract][Full Text] [Related]
6. Selective in situ protein expression profiles correlate with distinct phenotypes of basal cell carcinoma and squamous cell carcinoma of the skin.
Stelkovics E; Kiszner G; Meggyeshazi N; Korom I; Varga E; Nemeth I; Molnar J; Marczinovits I; Krenacs T
Histol Histopathol; 2013 Jul; 28(7):941-54. PubMed ID: 23446646
[TBL] [Abstract][Full Text] [Related]
7. Anaplastic neoplasms arising from basal cellcarcinoma xenotransplants into SCID-beige mice.
Carlson JA; Combates NJ; Stenn KS; Prouty SM
J Cutan Pathol; 2002 May; 29(5):268-78. PubMed ID: 12100626
[TBL] [Abstract][Full Text] [Related]
8. Variations in clinical presentation of basal cell carcinoma.
Buljan M; Bulat V; Situm M; Mihić LL; Stanić-Duktaj S
Acta Clin Croat; 2008 Mar; 47(1):25-30. PubMed ID: 18714644
[TBL] [Abstract][Full Text] [Related]
9. A novel tumor suppressor gene in basal cell carcinoma: inhibition of growth factor-2.
Temel M; Turkmen A; Dokuyucu R; Cevik C; Oztuzcu S; Cengiz B; Mutaf M
Tumour Biol; 2015 Jun; 36(6):4611-6. PubMed ID: 25613071
[TBL] [Abstract][Full Text] [Related]
10. Advances in the treatment of Basal cell carcinoma: Hedgehog inhibitors.
Kudchadkar R; Lewis K; Gonzalez R
Semin Oncol; 2012 Apr; 39(2):139-44. PubMed ID: 22484185
[TBL] [Abstract][Full Text] [Related]
11. Xeroderma pigmentosum complementation group C protein (XPC) expression in basal cell carcinoma.
Yang LC; Hsiao YP; Lu CT; Huang CH; Chao WR; Lin YT; Su HA; Chang SL; Chung JG
In Vivo; 2015; 29(1):35-8. PubMed ID: 25600527
[TBL] [Abstract][Full Text] [Related]
12. Recurrent NMYC copy number gain and high protein expression in basal cell carcinoma.
Freier K; Flechtenmacher C; Devens F; Hartschuh W; Hofele C; Lichter P; Joos S
Oncol Rep; 2006 May; 15(5):1141-5. PubMed ID: 16596176
[TBL] [Abstract][Full Text] [Related]
13. [Basal cell cancer--current research sheds new light].
Ståhle-Bäckdahl M
Nord Med; 1995; 110(3):82-4. PubMed ID: 7892123
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of cytokeratin 15, TDAG51, cytokeratin 20 and androgen receptor in sclerosing adnexal neoplasms and variants of basal cell carcinoma.
Evangelista MT; North JP
J Cutan Pathol; 2015 Nov; 42(11):824-31. PubMed ID: 26016446
[TBL] [Abstract][Full Text] [Related]
15. Chemopreventive opportunities to control basal cell carcinoma: Current perspectives.
Tilley C; Deep G; Agarwal R
Mol Carcinog; 2015 Sep; 54(9):688-97. PubMed ID: 26053157
[TBL] [Abstract][Full Text] [Related]
16. Discordant expression of desmoglein 2 and 3 at the mRNA and protein levels in nodular and superficial basal cell carcinoma revealed by immunohistochemistry and fluorescent in situ hybridization.
Pietkiewicz P; Gornowicz-Porowska J; Bowszyc-Dmochowska M; Jagielska J; Helak-Łapaj C; Kaczmarek E; Dmochowski M
Clin Exp Dermatol; 2014 Jul; 39(5):628-35. PubMed ID: 24934917
[TBL] [Abstract][Full Text] [Related]
17. Expression of mismatch repair enzymes, hMLH1 and hMSH2 is not associated with microsatellite instability and P53 protein accumulation in basal cell carcinoma.
Saetta AA; Aroni K; Stamatelli A; Lazaris AC; Patsouris E
Arch Dermatol Res; 2005 Sep; 297(3):99-107. PubMed ID: 16012876
[TBL] [Abstract][Full Text] [Related]
18. Expression of drebrin, an actin binding protein, in basal cell carcinoma, trichoblastoma and trichoepithelioma.
Mizutani Y; Iwamoto I; Kanoh H; Seishima M; Nagata K
Histol Histopathol; 2014 Jun; 29(6):757-66. PubMed ID: 24346822
[TBL] [Abstract][Full Text] [Related]
19. Expanding the Genetic Profile of BCC.
Cancer Discov; 2016 May; 6(5):OF2. PubMed ID: 27006369
[TBL] [Abstract][Full Text] [Related]
20. Molecular classification of basal cell carcinoma of skin by gene expression profiling.
Jee BA; Lim H; Kwon SM; Jo Y; Park MC; Lee IJ; Woo HG
Mol Carcinog; 2015 Dec; 54(12):1605-12. PubMed ID: 25328065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
